Improving access to biomarker data for cancer research
Official title: Enhancing and making Biomarker Knowledge FAIR using contextual CFDE data
Funded at George Washington University · NIH-10994366 · Data updated 2026-11-12
This study is working to make cancer biomarker information easier to find and use, so patients can better understand how these markers can help with cancer detection and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $975,028 |
| NIH project number | 1U24OD038423-01 |
| Project ID | NIH-10994366 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with cancer or those at high risk for developing cancer.
✕Less likely to help
Patients with non-cancerous conditions or those not involved in biomarker research may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the organization and accessibility of biomarker data, particularly in relation to cancer. By developing a comprehensive biomarker data model, the project aims to harmonize existing data and connect it with the Common Fund Data Ecosystem. Patients can benefit from this initiative as it will facilitate better understanding and utilization of biomarkers in cancer detection and treatment. The project involves collaboration with the Early Detection Research Network to ensure that the data model is robust and adaptable to new technologies.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer detection and treatment options through better utilization of biomarker data.
How similar studies have gone: Previous research initiatives have successfully improved biomarker data accessibility and utilization, indicating a promising potential for this approach.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Mazumder, Raja — George Washington University
- Study coordinator: Mazumder, Raja
Related research
Other NIH-funded projects on the same topics.
-
HLA-F and KIR3DS1: unlocking NK cell help to control HIV
A short, patient-friendly look at how a specific immune interaction might help the body control HIV and reduce long-term health problems.
-
Emerging therapies for rare maternal mitochondrial diseases with shared causes
A basket clinical trial will test new drug candidates for two ultra-rare mitochondrial diseases (MELAS and LHON-Plus) that share the same underlying energy-making problem in people who could be affected.
-
Anti-cancer vaccine for liver fluke infection and bile duct cancer
A vaccine approach aims to stop liver fluke interactions with the human bile ducts to prevent bile duct cancer in regions where the parasite is common.
-
Anti-cancer vaccine targeting the host-parasite interface during liver fluke infection
A vaccine approach aims to block how a liver fluke parasite communicates with the human liver to prevent bile duct cancer in people in Southeast Asia.
-
Understanding why youth develop type 2 diabetes and how to prevent it
A nationwide study aims to unravel why some teens with obesity develop type 2 diabetes while others don’t, and to identify factors that could help prevent it.
-
Ultrasensitive antibody-detection method to screen HIV-bNAbs
A new, ultra-sensitive test will help identify which broadly neutralizing antibodies can best block HIV-1 in people, by quickly checking how well these antibodies interact with the virus in patient-derived samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.